share_log

14,296 Shares in Livent Co. (NYSE:LTHM) Bought by Avantax Advisory Services Inc.

14,296 Shares in Livent Co. (NYSE:LTHM) Bought by Avantax Advisory Services Inc.

持有 Livent Co. 14,296 股股份(纽约证券交易所代码:LTHM)被 Avantax Advisory Services Inc. 收购
Defense World ·  2023/01/25 06:01

Avantax Advisory Services Inc. acquired a new position in Livent Co. (NYSE:LTHM – Get Rating) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 14,296 shares of the company's stock, valued at approximately $438,000.

Avantax 咨询服务公司收购了 Livent Co. 的新职位。(纽约证券交易所代码:LTHM — Get Rating)在向美国证券交易委员会提交的最新文件中表示,该公司在第三季度上涨。该公司收购了该公司14,296股股票,价值约43.8万美元。

A number of other institutional investors and hedge funds also recently made changes to their positions in LTHM. Lindbrook Capital LLC increased its stake in Livent by 2,902.7% in the second quarter. Lindbrook Capital LLC now owns 1,111 shares of the company's stock valued at $25,000 after acquiring an additional 1,074 shares during the last quarter. First Personal Financial Services bought a new position in Livent in the third quarter valued at $25,000. Credit Agricole S A bought a new position in Livent in the second quarter valued at $29,000. SeaCrest Wealth Management LLC bought a new position in Livent in the second quarter valued at $30,000. Finally, Sargent Bickham Lagudis LLC bought a new position in Livent in the third quarter valued at $35,000. Hedge funds and other institutional investors own 90.62% of the company's stock.

其他一些机构投资者和对冲基金最近也更改了他们在LTHM的头寸。林德布鲁克资本有限责任公司在第二季度将其在Livent的股份增加了2,902.7%。Lindbrook Capital LLC在上个季度又收购了1,074股股票后,现在拥有该公司1,111股股票,价值25,000美元。First Personal Financial Services在第三季度在Livent购买了一个价值25,000美元的新头寸。法国农业信贷银行股份有限公司在第二季度在Livent购买了价值29,000美元的新头寸。SeaCrest Wealth Management LLC在第二季度在Livent购买了一个价值3万美元的新头寸。最后,Sargent Bickham Lagudis LLC在第三季度收购了Livent的新头寸,价值35,000美元。对冲基金和其他机构投资者拥有该公司90.62%的股票。

Get
获取
Livent
Livent
alerts:
警报:

Livent Stock Up 1.1 %

Livent 股票上涨了 1.1%

NYSE LTHM opened at $25.55 on Wednesday. The company has a debt-to-equity ratio of 0.18, a current ratio of 3.52 and a quick ratio of 2.65. The stock has a market capitalization of $4.58 billion, a PE ratio of 25.55 and a beta of 1.76. Livent Co. has a 1 year low of $18.26 and a 1 year high of $36.38. The business's 50-day moving average is $23.81 and its 200 day moving average is $27.25.

纽约证券交易所LTHM周三开盘价为25.55美元。该公司的债务与权益比率为0.18,流动比率为3.52,速动比率为2.65。该股的市值为45.8亿美元,市盈率为25.55,beta值为1.76。Livent Co. 创下1年低点18.26美元,1年高点为36.38美元。该公司的50天移动平均线为23.81美元,其200天移动平均线为27.25美元。

Livent (NYSE:LTHM – Get Rating) last issued its quarterly earnings data on Tuesday, November 1st. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. Livent had a net margin of 27.67% and a return on equity of 20.00%. The business had revenue of $231.60 million during the quarter, compared to analyst estimates of $248.19 million. Sell-side analysts forecast that Livent Co. will post 1.35 earnings per share for the current year.
Livent(纽约证券交易所代码:LTHM — Get Rating)上次发布季度收益数据是在11月1日星期二。该公司公布本季度每股收益0.41美元,达到共识预期的0.41美元。Livent的净利润率为27.67%,股本回报率为20.00%。该业务在本季度的收入为2.316亿美元,而分析师的估计为2.4819亿美元。卖方分析师预测,Livent Co. 今年将公布每股收益1.35美元。

Analyst Ratings Changes

分析师评级变化

A number of research firms recently commented on LTHM. Deutsche Bank Aktiengesellschaft reduced their target price on Livent from $30.00 to $22.00 in a research note on Tuesday, January 10th. Raymond James raised their price objective on Livent from $33.00 to $35.00 and gave the company an "outperform" rating in a research note on Thursday, October 13th. Vertical Research raised Livent from a "hold" rating to a "buy" rating and set a $30.00 price objective on the stock in a research note on Wednesday, January 4th. B. Riley raised their price objective on Livent from $30.00 to $32.00 and gave the company a "neutral" rating in a research note on Thursday, October 27th. Finally, Piper Sandler reduced their price objective on Livent from $42.00 to $38.00 and set an "overweight" rating on the stock in a research note on Thursday, December 15th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $28.78.

许多研究公司最近对LTHM发表了评论。德意志银行Aktiengesellschaft在1月10日星期二的一份研究报告中将Livent的目标价格从30.00美元下调至22.00美元。雷蒙德·詹姆斯在10月13日星期四的一份研究报告中将Livent的目标价格从33.00美元上调至35.00美元,并将该公司评为 “跑赢大盘”。Vertical Research在1月4日星期三的一份研究报告中将Livent的评级从 “持有” 上调至 “买入”,并为该股设定了30.00美元的价格目标。B. Riley在10月27日星期四的一份研究报告中将Livent的目标价格从30.00美元上调至32.00美元,并将该公司评为 “中性”。最后,派珀·桑德勒将Livent的目标价格从42.00美元下调至38.00美元,并在12月15日星期四的一份研究报告中对该股设定了 “增持” 评级。一位分析师对该股进行了卖出评级,四位分析师给出了持有评级,七位给出了买入评级。根据MarketBeat的数据,该公司目前的共识评级为 “适度买入”,平均目标价为28.78美元。

Livent Profile

Livent 个人资料

(Get Rating)

(获取评分)

Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.

Livent Corporation 生产和销售高性能锂化合物,主要用于北美、拉丁美洲、欧洲、中东、非洲和亚太地区的锂基电池、特种聚合物和化学合成应用。该公司提供用于具有特定性能要求的应用的锂化合物,包括用于高性能锂离子电池的电池级氢氧化锂;以及用于生产聚合物和药品的丁基锂,以及一系列特种锂化合物,包括用于不可充电电池和航空航天应用轻质材料生产的高纯度锂金属。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on Livent (LTHM)
  • Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
  • How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
  • Is the Pain Over for Baudax Bio Investors after a 70% Spike?
  • Will Rocket Lab's First U.S. Launch Send Stock Into Stratosphere?
  • 3 Retail Stocks Ringing the Register in 2023
  • 免费获取 StockNews.com 关于 Livent 的研究报告 (LTHM)
  • Pliant Therapeutics 的差距上涨了 34%:还有更多上行空间?
  • 2023 年初的裁员将如何影响这5只生物技术股?
  • 在飙升70%之后,Baudax Bio投资者的痛苦结束了吗?
  • 火箭实验室在美国的首次发射会将股票送入平流层吗?
  • 2023 年有 3 只零售股大放异彩了

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.

接收 Livent Daily 的新闻和评级 -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Livent及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发